GlassScriptPhysician profile
Ryan C Wiygul
NPI 1174807135
$1,336.52
in general payments reported to CMS, 2019-2025
14 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.26 · 2022: $332 · 2023: $359 · 2024: $187 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $504.60 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $136.06 | 2022-2025 | |
| Amgen INC. | $108.16 | 2021-2025 | Evenity, Prolia |
| Zimmer Biomet Holdings, INC. | $87.44 | 2023 | Persona, Rosa, Subchondroplasty Knee Kit |
| Lilly USA, LLC | $87.15 | 2022-2024 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $83.35 | 2022-2025 | Wegovy |
| Astellas Pharma US INC | $76.76 | 2024-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $66.14 | 2022-2023 | Fasenra |
| Boston Scientific Corporation | $62.80 | 2025 | Watchman Flx |
| Bausch Health US, LLC | $33.59 | 2021 | |
| Acella Pharmaceuticals, LLC | $29.64 | 2025 | NP Thyroid 60 |
| Ethicon US, LLC | $21.22 | 2022 | |
| Intuitive Surgical, INC. | $19.84 | 2022 | |
| Glaxosmithkline, LLC. | $19.77 | 2024 | Arexvy, Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Wiygul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.